NAMS SCHEDULE 13G/A: SEC filing
RA Capital Management, L.P. and affiliated reporting persons
Filed with the SEC on · accession 0001346824-26-000287
NAMS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 12,207,198 ordinary shares of NewAmsterdam Pharma Company N.V., representing 9.99% of outstanding shares as of September 30, 2026, a passive investment position.
Key details
✦ Ask GOAX AI about this filing — what it means for NAMS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NAMS?
Click hereFrequently asked questions
What did NAMS file with the SEC on Nov 16, 2026?
NAMS filed a SCHEDULE 13G/A (SEC filing). RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 12,207,198 ordinary shares of NewAmsterdam Pharma Company N.V., representing 9.99% of outstanding shares as of September 30, 2026, a passive investment position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other NAMS SEC filings
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 8-K · SEC filingNov 4, 2026
- 10-Q · SEC filingNov 4, 2026
- 8-K · Fda approvalSep 29, 2026
- SCHEDULE 13D/A · SEC filingSep 22, 2026
- 8-K · Fda approvalSep 21, 2026
- 8-K · Executive departureAug 14, 2026
- 8-K · Executive departureAug 14, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
Get alerts when NAMS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days